Why Study Design Matters in Collagen Supplement Research

In June 2025, a meta-analysis by Myung & Park made waves by concluding there is “no clinical evidence” that collagen supplements benefit skin aging. Their analysis suggested that any positive effects seen in previous trials disappeared when you select for "independent" or "high-quality" studies. Such a conclusion, presented without nuance, risks shaping public and professional opinion against collagen supplementation. But does the full body of evidence really support this claim?

Why the Meta-Analysis Misses Key Context

A closer examination shows important gaps in the meta-analysis. Many of the “independent” trials it relied on were poorly positioned to detect meaningful results – often underdosed (1 – 2.5 g/day, far below the ~5 g/day supported by prior research) or too short in duration (as little as 8 weeks, insufficient for dermal remodeling). These limitations make it unlikely such studies would detect the structural skin changes that collagen can produce.

When collagen is studied under appropriate conditions – proper dosing, at least 12–16 weeks of supplementation, and rigorous trial design – consistent benefits emerge. For example, a 16-week randomized, double-blind, placebo-controlled study published in Nutrients (Žmitek et al., 2024) tested 5 g/day of collagen with vitamin C. The results showed significant improvements in dermal density, skin texture, and wrinkle depth, while hydration and elasticity remained unchanged – a pattern consistent with collagen’s known role in strengthening the dermal matrix rather than altering superficial hydration.

Understanding the Real Takeaway

Even Myung & Park’s own pooled data showed statistically significant improvements in wrinkles, elasticity, and hydration across all studies. Instead of dismissing these results, a better approach is to understand why certain subgroup analyses appear weaker. The answer lies in the details: dose, duration, population, and choice of outcome measures.

The broader scientific takeaway is clear: collagen’s efficacy depends on how it is studied, not simply on whether the research was industry-funded. Declaring collagen ineffective oversimplifies a nuanced body of evidence and risks discouraging further high-quality research. The more productive question is not “does collagen work?” but “which collagen works, for whom, and under what conditions?” When those conditions are met, collagen supplementation remains a promising, evidence-backed approach to supporting skin structure and reducing visible signs of aging.

Read the full review of meta-analysis: Why the Latest Meta-Analysis on Collagen Misses the Mark 

Share article:

Subscribe to In_sider newsletter

By clicking “Subscribe” button I agree to let Tosla d.o.o. collect and process my personal data as stated in Privacy Policy.